Updates in Melanoma: A Focus on Neoadjuvant Approaches
With new regimens emerging as viable options for neoadjuvant therapy, clinicians should be aware of the changing landscape in initial cutaneous melanoma treatment options. It will be essential for the clinician to identify patients who would benefit from neoadjuvant intervention versus a more traditional surgical or systemic therapy approach.
Category
  • Melanoma
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Cost $0.00
CRS and ICANS Management in CAR T/Bispecific Antibody Therapies
As these therapies continue to evolve, it is imperative that nursing policies are created/revised and shared with nursing staff to remain up to date on current clinical practice for these complications. With continued education and reinforcement of protocols, nurses can positively impact patient outcomes.
Category
  • Management of Immunotherapy-Related Toxicities
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Cost $0.00
Advances in Antiemesis Management for Patients with Cancer
Recent clinical trials continue to enhance available data on the use of olanzapine for emesis prevention in parenteral anticancer agents with high and moderate emetogenic risk as well as for breakthrough treatment and an alternative to dexamethasone for delayed anticancer induced nausea/vomiting. Clinicians should be aware of these updates and how they apply to appropriate patients.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
Cost $0.00
Updates in Metastatic Colorectal Cancer
As options for treatment of metastatic colorectal cancer evolve, clinicians can benefit from education about available options and criteria for selecting the appropriate option to offer their patients. An overview of these newer treatment options, and the data supporting these, should help clinicians better serve their patients with metastatic colorectal cancer.
Category
  • Colorectal Cancer
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
Cost $0.00
Treatment Updates for Small Cell Lung Cancer
After decades of no change in treatment, practice changing therapies have now been added to the NCCN Guidelines for Small Cell Lung Cancer. This activity will help clinicians keep up to date with practice-changing strategies for SCLC.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
Cost $0.00
Plenary Session: Artificial Intelligence in Cancer Care: Opportunities, Challenges, and Governance
Education in this topic is important as AI is increasingly incorporated into care settings. Practitioners may not be aware of the way AI is currently being used or of its potential future application. Additionally, healthcare professionals need to be informed of the policy environment for the safe and effective use of AI in healthcare settings.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • 1.25 AAPA Category 1 CME credit
  • 1.25 ACPE contact hours
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 ANCC contact hours
  • 1.25 Participation
Cost $0.00
Artificial Intelligence: Evaluation and Success Criteria for AI Tools
With the promise of artificial intelligence (AI) and its potential to positively impact healthcare, comes the challenge of how to assess the feasibility and value associated with implementation of AI tools.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
Cost $0.00
Improving Clinical Trial Accrual: Doing More with Less
Traditional recruitment to clinical trials was accomplished by outreach from the treating physician or staff associated with the clinical trial. It is important for clinicians to be aware of the logistics and the value that a clinical trial matching tool can bring to presenting a person with cancer the appropriate clinical trial.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
Cost $0.00
Expanding the Reach of Clinical Trials
Although we have made some progress in ways of increasing clinical trial access to underserved communities, inequities persist. Education in this area is important because increasing access to clinical trials will have a positive impact on patient outcomes and help address current disparities in cancer treatment.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
Cost $0.00
Innovative Strategies to Improve Patient Access
Technology advancements in recent years have created many opportunities for improving patient access, including opportunities for self-scheduling. As practices are investing significant resources in this space it is important to understand the challenges, limitations, and impacts of these innovative approaches to solving patient access issues.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Cost $0.00

Pages